Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Hexokinase-2 Regulates Hypoxia-Inducible Autophagy, Leading to Enhance Anti-Apoptotic Capability of Refractory Multiple Myeloma

Sho Ikeda, MD PhD, Fumito Abe, MD PhD, Matsuda Yuka, Akihiro Kitadate, MD PhD, Takahiro Kobayashi, MD PhD, Naoto Takahashi, MD PhD, Hiroyuki Tagawa, MD PhD

Blood (2019) 134 (Supplement_1): 1787.

https://doi.org/10.1182/blood-2019-123360

Published: 2019

Journal Articles

Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas

Akihiro Kitadate, MD, Sho Ikeda, MD, Fumito Abe, MD PhD, Naoto Takahashi, MD PhD, Norio Shimizu, PhD, Kosei Matsue, MD PhD, Hiroyuki Tagawa, MD PhD

Blood (2017) 130 (Supplement 1): 720.

https://doi.org/10.1182/blood.V130.Suppl_1.720.720

Published: 2017

Journal Articles

Hypoxia-Inducible KDM3A Addiction in Multiple Myeloma

Sho Ikeda, MD, Akihiro Kitadate, MD, Fumito Abe, MD PhD, Naoto Takahashi, Hiroyuki Tagawa, MD PhD

Blood (2017) 130 (Supplement 1): 3061.

https://doi.org/10.1182/blood.V130.Suppl_1.3061.3061

Published: 2017

Journal Articles

Histone Deacetylase Inhibitors Inhibit Metastasis By Restoring a Tumor Suppressive microRNA, Mir-150 in Advanced Cutaneous T-Cell Lymphoma

Akihiro Kitadate, MD PhD, Fumito Abe, MD, Sho Ikeda, MD PhD, Junsuke Yamashita, Naoto Takahashi, MD PhD, Makoto Sugaya, MD PhD, Hiroyuki Tagawa, MD PhD

Blood (2016) 128 (22): 4113.

https://doi.org/10.1182/blood.V128.22.4113.4113

Published: 2016

Journal Articles

Hypoxia Inducible microRNA-210 Regulates the DIMT1-IRF4 Oncogenetic Axis in Multiple Myeloma

Sho Ikeda, MD PhD, Akihiro Kitadate, MD PhD, Fumito Abe, MD, Naoto Takahashi, MD PhD, Hiroyuki Tagawa, MD PhD

Blood (2016) 128 (22): 2058.

https://doi.org/10.1182/blood.V128.22.2058.2058

Published: 2016

Journal Articles

Microrna-16 Mediates the Regulation of a Senescence-Apoptosis Switch in Cutaneous T-Cell and Other Non-Hodgkin Lymphomas

Akihiro Kitadate, MD, Sho Ikeda, MD, Kazuaki Teshima, MD PhD, Mitsugu Ito, MD PhD, Naoto Takahashi, MD PhD, Tomomitsu Miyagaki, MD PhD, Makoto Sugaya, MD PhD, Hiroyuki Tagawa, MD PhD

Blood (2015) 126 (23): 467.

https://doi.org/10.1182/blood.V126.23.467.467

Published: 2015

Journal Articles

Microrna-150 Inhibits Tumor Invasion and Metastasis By Targeting The Chemokine Receptor CCR6 In Advanced Cutaneous T-Cell Lymphoma

Mitsugu Ito, MD, Kazuaki Teshima, MD, Sho Ikeda, MD, Atsushi Watanabe, MD, PhD, Miho Nara, MD, Akihiro Kitadate, MD, Junsuke Yamashita, Koichi Oshima, MD, PhD, Kenichi Sawada, MD, PhD, Hiroyuki Tagawa, MD, PhD

Blood (2013) 122 (21): 4248.

https://doi.org/10.1182/blood.V122.21.4248.4248

Published: 2013

Journal Articles

Bortezomib Is Effective for Down Regulation of Gene Transcriptions Specifically Expressed in Clonogenic Myeloma Side Population Cells

Miho Nara, MD, Hiroyuki Tagawa, MD, PhD, Kazuaki Teshima, MD, Atsushi Watanabe, MD, PhD, Mitsugu Ito, MD, Atsushi Kitabayashi, MD, PhD, Masaaki Kume, MD, PhD, Yoshiaki Hatano, MD, PhD, Shinsuke Iida, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2012) 120 (21): 3939.

https://doi.org/10.1182/blood.V120.21.3939.3939

Published: 2012

Journal Articles

Microrna-16 Regulates BMI1 in the Clonogenic Side Population of Refractory Mantle Cell Lymphoma

Kazuaki Teshima, MD, Miho Nara, MD, Atsushi Watanabe, MD, PhD, Mitsugu Ito, MD, Yoshiaki Hatana, MD, PhD, Naoto Takahashi, MD, PhD, Kouichi Oshima, MD, PhD, Kenichi Sawada, MD, PhD, Hiroyuki Tagawa, MD, PhD

Blood (2012) 120 (21): 861.

https://doi.org/10.1182/blood.V120.21.861.861

Published: 2012

Journal Articles

Possibility of Lenalidomide Therapy and Determination of Its Ideal Dose for Patients with Relapsed or Refractory Multiple Myeloma

Seiji Shida, MD, Naoto Takahashi, MD, PhD, FJSIM, Masatomo Miura, PhD, Takenori Niioka, PhD, Morio Matsumoto, MD, Masao Hagihara, MD, Mutsuhito Motegi, MD, PhD, Masaaki Kume, MD, PhD, Jun Kuroki, MD, PhD, Atsushi Kitabayashi, MD, PhD, Yoshiaki Hatano, MD, PhD, Atsushi Watanabe, MD, PhD, Naohito Fujishima, MD, PhD, Yoshihiro Kameoka, MD, PhD, Hiroyuki Tagawa, MD, PhD, Makoto Hirokawa, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2012) 120 (21): 4921.

https://doi.org/10.1182/blood.V120.21.4921.4921

Published: 2012

Journal Articles

CDR3-Independent Expansion of Vδ1 γδ T Lymphocytes and Depletion of Vδ2 T Cells Are Unique Features in Acquired Chronic Pure Red Cell Aplasia,

Michishita Yoshihiro, MD, Makoto Hirokawa, MD, PhD, Naohito Fujishima, MD, PhD, Yukiko Abe, Masumi Fujishima, MD, PhD, Yong-Mei Guo, MD, PhD, Kumi Ubukawa, MD, Liu Jiajia, MD, Tomoko Yoshioka, MD, PhD, Yoshihiro Kameoka, MD, PhD, Hirobumi Saitoh, MD, PhD, Hiroyuki Tagawa, MD, PhD, Naoto Takahashi, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2011) 118 (21): 3429.

https://doi.org/10.1182/blood.V118.21.3429.3429

Published: 2011

Journal Articles

Dasatinib Cerebrospinal Fluid Concentration and Plasma Pharmacokinetics: Potential for Central Nervous System Prophylaxis In Philadelphia Chromosome-Positive Leukemia

Naoto Takahashi, MD, PhD, Masatomo Miura, PhD, Stuart Scott, PhD, Hirobumi Saitoh, MD, PhD, Mutsuhito Motegi, MD, PhD, Naohito Fujishima, MD, PhD, Yoshihiro Kameoka, MD, PhD, Hiroyuki Tagawa, MD, PhD, Makoto Hirokawa, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2010) 116 (21): 1807.

https://doi.org/10.1182/blood.V116.21.1807.1807

Published: 2010

Journal Articles

The Role of Mir-150 as a Tumor Suppressor In Malignant Lymphoma

Atsushi Watanabe,, MD, Hiroyuki Tagawa, MD, PhD, Kazuaki Teshima, MD, Yoshihiro Kameoka, MD, PhD, Naoto Takahashi, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2010) 116 (21): 465.

https://doi.org/10.1182/blood.V116.21.465.465

Published: 2010

Journal Articles

MicroRNA-17-92 Downregulates Expression of Distinct Targets in Different B-Cell Lymphoma Subtypes

Hiroyuki Tagawa, MD, PhD, Mika Inomata, MD, Yong-Mei Guo, MD, Yoshihiro Kameoka, MD, PhD, Naoto Takahashi, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2008) 112 (11): 5321.

https://doi.org/10.1182/blood.V112.11.5321.5321

Published: 2008

Journal Articles

Identification of Subtype-Specific Genomic Alterations of Acute and Lymphoma Types of Adult T-Cell Leukemia/Lymphoma.

Aya Oshiro, MD, Hiroyuki Tagawa, MD, PhD, Kouichi Oshima, MD, PhD, Kennosuke Karube, MD, Naokuni Uike, MD, PhD, Yukie Tashiro, MD, PhD, Atae Utsunomiya, MD, PhD, Masato Masuda, MD, PhD, Yasuo Morishima, MD, PhD, Shigeo Nakamura, MD, PhD, Masao Seto, MD, PhD

Blood (2005) 106 (11): 4667.

https://doi.org/10.1182/blood.V106.11.4667.4667

Published: 2005

Journal Articles

A microRNA Cluster as a Target of Genomic Amplification in B-Cell Lymphomas.

Hiroyuki Tagawa, MD, PhD, Kennosuke Karbe, MD, Koichi Ohshima, MD, PhD, Yasuo Morishima, MD, PhD, Shigeo Nakamura, MD, PhD, Masao Seto, MD, PhD

Blood (2005) 106 (11): 3011.

https://doi.org/10.1182/blood.V106.11.3011.3011

Published: 2005

Journal Articles

Genome-Wide Array-Based CGH for Mantle Cell Lymphoma: Precise Mapping of Genomic Aberrations and Identification of Novel Candidate Genes.

Hiroyuki Tagawa, MD, PhD, Siversundram Karnan, Ritsuro Suzuki, MD, PhD, Akinobu Ota, Shinobu Tsuzuki, MD, PhD, Yasuo Morishima, MD, PhD, Shigeo Nakamura, MD, PhD, Masao Seto, MD, PhD

Blood (2004) 104 (11): 2890.

https://doi.org/10.1182/blood.V104.11.2890.2890

Published: 2004

NARROW

Hexokinase-2 Regulates Hypoxia-Inducible Autophagy, Leading to Enhance Anti-Apoptotic Capability of Refractory Multiple Myeloma

Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas

Hypoxia-Inducible KDM3A Addiction in Multiple Myeloma

Histone Deacetylase Inhibitors Inhibit Metastasis By Restoring a Tumor Suppressive microRNA, Mir-150 in Advanced Cutaneous T-Cell Lymphoma

Hypoxia Inducible microRNA-210 Regulates the DIMT1-IRF4 Oncogenetic Axis in Multiple Myeloma

Microrna-16 Mediates the Regulation of a Senescence-Apoptosis Switch in Cutaneous T-Cell and Other Non-Hodgkin Lymphomas

Microrna-150 Inhibits Tumor Invasion and Metastasis By Targeting The Chemokine Receptor CCR6 In Advanced Cutaneous T-Cell Lymphoma

Bortezomib Is Effective for Down Regulation of Gene Transcriptions Specifically Expressed in Clonogenic Myeloma Side Population Cells

Microrna-16 Regulates BMI1 in the Clonogenic Side Population of Refractory Mantle Cell Lymphoma

Possibility of Lenalidomide Therapy and Determination of Its Ideal Dose for Patients with Relapsed or Refractory Multiple Myeloma

CDR3-Independent Expansion of Vδ1 γδ T Lymphocytes and Depletion of Vδ2 T Cells Are Unique Features in Acquired Chronic Pure Red Cell Aplasia,

Dasatinib Cerebrospinal Fluid Concentration and Plasma Pharmacokinetics: Potential for Central Nervous System Prophylaxis In Philadelphia Chromosome-Positive Leukemia

The Role of Mir-150 as a Tumor Suppressor In Malignant Lymphoma

MicroRNA-17-92 Downregulates Expression of Distinct Targets in Different B-Cell Lymphoma Subtypes

Identification of Subtype-Specific Genomic Alterations of Acute and Lymphoma Types of Adult T-Cell Leukemia/Lymphoma.

A microRNA Cluster as a Target of Genomic Amplification in B-Cell Lymphomas.

Genome-Wide Array-Based CGH for Mantle Cell Lymphoma: Precise Mapping of Genomic Aberrations and Identification of Novel Candidate Genes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only